AZ Forxiga DAPA CKD

Objective

The purpose of this study is to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.

Last Updated: 07/12/2017

Research Study Categories

  • Adult Studies

Specialty

  • Nephrology
Contact
Clinical Trials at 866-839-4128
or clinicaltrials@eirh.org